Genetic Testing: A New Dawn in Healthcare


In the rapidly evolving landscape of healthcare, genetic testing is emerging as a pivotal force, promising to transform patient care through precision medicine. The insights derived from our genetic codes hold the potential to not only prevent diseases but also optimize treatments and promote healthier living. Yet, as highlighted in a recent MedCity News article, the journey towards realizing this potential is fraught with challenges, particularly around patient privacy and data sharing.

The Role of Information Technology


A critical component in addressing these challenges is information technology security. Organizations are turning to certifications like HITRUST to establish standards for safeguarding sensitive information. By aligning with these standards, they can protect data while facilitating the sharing necessary to enhance medical knowledge and patient care.

Collaborative Efforts and Data Sharing


Collaboration is at the heart of advancing genetic testing. Companies are contributing de-identified variant data to public health databases such as ClinVAR and the SEER Cancer Registries. These efforts, supported by cancer research registries, deepen insights and expedite advancements in patient care.
The analysis of expansive data sets is crucial for understanding diseases, allowing researchers to access, assess, and test hypotheses. This collaborative approach is paving the way for tailored treatment plans and new biological discoveries, enhancing early disease detection and intervention.

Integration with Electronic Health Records


Integrating genetic testing with Electronic Health Records (EHR) is another key strategy for improving patient outcomes. Collaborations with EHR vendors like Epic, Flatiron, and Athena streamline processes, making it easier for providers to order genetic products, optimize screening protocols, and identify potential pharmacogenetic interactions. Such collaborations break down silos, enhancing data exchange for more effective research and patient care.

Challenges and Future Trends


Despite the promising progress, the integration of genetic testing into mainstream medicine presents challenges, including managing the vast volume of genomic data. Companies are focusing on presenting complex clinical interpretations, integrating common data ontologies, overcoming data fragmentation, and ensuring data privacy to address these hurdles.
Looking ahead, the industry anticipates significant advancements, with trends like developing tests for early cancer recurrence detection and embracing a multi-omics approach that integrates RNA, proteins, and AI insights. The integration of generative AI for documentation and genetic counseling is another notable development on the horizon.

A New Era in Healthcare


Genetic testing represents more than just a scientific advancement; it signifies a fundamental shift in how we approach health and wellness. As public understanding grows and technology advances, we find ourselves at the dawn of a new era in healthcare, where our genetic code becomes a roadmap to better health and longevity.
Kevin haas, chief technology officer at myriad genetics

About the Author


Kevin Haas, Ph.D., serves as the Chief Technology Officer at Myriad Genetics, where he leads the development of the precision medicine platform. With expertise in molecular simulation and machine learning, Haas is advancing genomics and digital patient/provider experiences. He has co-authored 16 peer-reviewed publications and nine patent applications, bringing a wealth of experience to his role.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Fed Survey Shows Only Two More Rate Cuts Expected, Even if Trump Appoints a New Fed Chair

A new CNBC Fed Survey reveals that economists expect just two additional interest rate cuts in 2026 and none in 2027, even if President Donald Trump appoints a more dovish Federal Reserve chair. Strong economic growth, stable inflation, and reduced recession fears are keeping rate‑cut expectations limited, signaling a more stable long‑term environment for real estate, mortgage, and financial professionals.

15 States on the Brink: America’s Insurance Crisis Is Spreading Faster Than Anyone Expected

A nationwide insurance crisis is accelerating as climate‑driven disasters push premiums higher, force insurers out of multiple states, and reshape real estate and mortgage markets. Once limited to Florida and California, the instability now threatens 15 states where losses, extreme weather, and insurer withdrawals are creating mounting risks for homeowners and industry professionals alike.

Commercial Real Estate in 2026: Rightsizing, Cool Offices, and a Market Waiting for Clarity

Commercial real estate is entering 2026 with a cautious but strategic shift. Companies are ditching oversized offices in favor of smaller, higher‑quality spaces packed with amenities that attract today’s workforce. Downtown markets like Portland remain steady, while suburban vacancies rise and landlords get creative with incentives. Industrial real estate is cooling after years of explosive growth, and developers are hesitating—though multifamily and hotel projects continue to push forward. Overall, the theme of the year is patience, as businesses wait for clearer signals on interest rates, construction costs, and long‑term workplace trends.

The Real Reason Housing Isn’t Affordable—And Why Deregulation Won’t Save Us

A new study from leading urban scholars reveals that zoning laws and construction slowdowns aren’t the true cause of America’s housing crisis. Even with massive building booms, rents would barely drop for decades. The real culprit? Soaring economic inequality. Until the widening wealth gap is addressed, policies like upzoning and deregulation won’t make housing affordable for working Americans—and may even push prices higher.

Cambio Raises $18M To Transform Commercial Real Estate Workflows With AI

Cambio, a fast‑growing AI proptech company, has secured an $18 million Series A at a $100 million valuation, aiming to overhaul how commercial real estate firms process documents and make investment decisions. By converting messy PDFs, spreadsheets, and audit files into investor‑ready insights in minutes, the platform is rapidly expanding—now active in 35 countries and managing data for over 2 billion square feet of assets.

Florida’s Insurance Market Enters 2026 With Rare Good News — Stability Returns for Homeowners and Real Estate Professionals

Florida’s insurance market is finally showing signs of real recovery heading into 2026. Industry leaders say recent legal reforms have sharply reduced lawsuits, allowing insurers to stabilize rates — and even introduce reductions for the first time in years. With new companies entering the state and solvency at its strongest level in more than a decade, real estate and mortgage professionals may benefit from improved buyer confidence and smoother closings as insurance becomes more predictable again.